Grufity logo
Grufity logo

Latest Eversept Partners, LP Stock Portfolio

$1.93Billion | No. of Holdings #116

Eversept Partners, LP Performance

2026 Q2+6.48%
YTD+2.84%
2025+19.86%

About Eversept Partners, LP and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Eversept Partners, LP reported an equity portfolio of $1.9 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Eversept Partners, LP are UTHR, , EHC. The fund has invested 8.1% of it's portfolio in UNITED THERAPEUTICS CORP DEL and 6.3% of portfolio in ABIVAX SA. <br><br> The fund managers got completely rid off HEALTHPEAK PROPERTIES INC (PEAK), AVANTOR INC (AVTR) and ICON PLC (ICLR) stocks. They significantly reduced their stock positions in REPLIGEN CORP (RGEN), BIO-TECHNE CORP (TECH) and ARCUTIS BIOTHERAPEUTICS INC (ARQT). Eversept Partners, LP opened new stock positions in CARETRUST REIT INC (CTRE), UNITEDHEALTH GROUP INC (UNH) and COGENT BIOSCIENCES INC (COGT). The fund showed a lot of confidence in some stocks as they added substantially to ENSIGN GROUP INC (ENSG), AGILON HEALTH INC (AGL) and ENCOMPASS HEALTH CORP (EHC).
Eversept Partners, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$1.93Billion
  as of Aug 14, 2026

Eversept Partners, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Eversept Partners, LP made a return of 6.48% in the last quarter. In trailing 12 months, it's portfolio return was 35.29%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
caretrust reit inc43,255,800
unitedhealth group inc21,257,400
cogent biosciences inc18,972,100
insmed inc15,908,700
amn healthcare svcs inc13,871,500
celcuity inc13,384,100
humana inc12,381,700
corvus pharmaceuticals inc11,175,000
New stocks bought by Eversept Partners, LP

Additions

Ticker% Inc.
ensign group inc3,978
agilon health inc435
agilon health inc435
encompass health corp429
tenet healthcare corp286
sonida senior living inc260
evommune inc219
ars pharmaceuticals inc176
Additions to existing portfolio by Eversept Partners, LP

Reductions

Ticker% Reduced
repligen corp-88.08
bio-techne corp-84.66
arcutis biotherapeutics inc-76.52
gsk plc-73.01
relmada therapeutics inc-66.47
assembly biosciences inc-59.62
anteris technologies global-58.57
natera inc-54.3
Eversept Partners, LP reduced stake in above stock

Sold off

Ticker$ Sold
avantor inc-23,318,400
healthpeak properties inc-32,549,000
esperion therapeutics inc ne-4,756,540
engene holdings inc-3,476,800
enhabit inc-3,204,780
agios pharmaceuticals inc-6,766,000
day one biopharmaceuticals i-3,942,860
bioventus inc-1,452,670
Eversept Partners, LP got rid off the above stocks

Sector Distribution

Eversept Partners, LP has about 77.9% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
  • Real Estate
Sector%
Healthcare77.9
Others15.9
Real Estate5.9

Market Cap. Distribution

Eversept Partners, LP has about 37.8% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • MEGA-CAP
  • MICRO-CAP
Category%
LARGE-CAP35.3
MID-CAP32.1
UNALLOCATED15.9
SMALL-CAP12.8
MEGA-CAP2.5
MICRO-CAP1.3

Stocks belong to which Index?

About 54.2% of the stocks held by Eversept Partners, LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others45.8
RUSSELL 200044.9
S&P 5009.3
Top 5 Winners (%)%
CMPS
compass pathways plc
155.3 %
IFRX
inflarx nv
131.0 %
definium therapeutics inc
108.5 %
LQDA
liquidia corporation
90.8 %
KPTI
karyopharm therapeutics inc
75.4 %
Top 5 Winners ($)$
LQDA
liquidia corporation
23.2 M
abivax sa
20.2 M
NTRA
natera inc
20.0 M
TVTX
travere therapeutics inc
18.2 M
CLDX
celldex therapeutics inc new
9.8 M
Top 5 Losers (%)%
LPCN
lipocine inc new
-68.0 %
grace therapeutics inc
-50.7 %
INO
inovio pharmaceuticals inc
-36.8 %
AGL
agilon health inc
-33.4 %
AGL
agilon health inc
-33.4 %
Top 5 Losers ($)$
UTHR
united therapeutics corp del
-14.1 M
ENSG
ensign group inc
-12.7 M
PODD
insulet corp
-8.4 M
HCA
hca healthcare inc
-7.4 M
SNDX
syndax pharmaceuticals inc
-4.3 M

Eversept Partners, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Eversept Partners, LP

Eversept Partners, LP has 116 stocks in it's portfolio. About 44.4% of the portfolio is in top 10 stocks. UTHR proved to be the most loss making stock for the portfolio. LQDA was the most profitable stock for Eversept Partners, LP last quarter.

$1.83BTotal Value
135Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Eversept Partners, LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change